ATORVASTATIN CALCIUM
These highlights do not include all the information needed to use CALCIUM TABLETS safely and effectively. See full prescribing information for CALCIUM TABLETS. CALCIUM tablets, for oral administration Initial U.S. Approval: 1996
Approved
Approval ID
56550295-7074-43f0-9f46-4b2dc852f881
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 7, 2017
Manufacturers
FDA
Unit Dose Services
DUNS: 831995316
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ATORVASTATIN CALCIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50436-9987
Application NumberANDA090548
Product Classification
M
Marketing Category
C73584
G
Generic Name
ATORVASTATIN CALCIUM
Product Specifications
Route of AdministrationORAL
Effective DateJuly 31, 2017
FDA Product Classification
INGREDIENTS (11)
CALCIUM ACETATEInactive
Code: Y882YXF34X
Classification: IACT
HYDROXYPROPYL CELLULOSE (1200000 MW)Inactive
Code: RFW2ET671P
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
ATORVASTATIN CALCIUMActive
Quantity: 10 mg in 1 1
Code: 48A5M73Z4Q
Classification: ACTIM
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SODIUM CARBONATEInactive
Code: 45P3261C7T
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT